BrainScan: The First Alzheimer's Blood Test for Consumers is Now Available
BrainScan features the high-sensitivity p-tau217 test * along with additional neurological biomarkers.
*Note: These tests alone do not provide a definitive diagnosis and should be interpreted by a qualified practitioner in conjunction with clinical signs and symptoms.
For more information on ordering the tests, please go to: https://www.apollohealthco.com/brainscan/
Unlike standard Alzheimer's disease tests, which do not turn positive until significant symptoms have occurred, Neurocode's high-sensitivity p-tau 217 detects biomarker changes years before symptoms of dementia occur, providing an opportunity for early treatment and better outcomes. For more information on the accuracy of these tests, please go to: https://jamanetwork.com/journals/jamaneurology/fullarticle/2813751
Dr.
Dr.
About Apollo Health: Apollo Health is a leading provider of innovative health solutions for cognition that empower individuals to optimize their well-being through personalized nutrition, lifestyle modifications, and cutting-edge research. With a team of world-class experts, Apollo Health™ is revolutionizing the approach to health and helping individuals thrive in all aspects of life.
View original content to download multimedia:https://www.prnewswire.com/news-releases/brainscan-the-first-alzheimers-blood-test-for-consumers-is-now-available-302199145.html
SOURCE Apollo Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Help End Pennsylvania's Transplant Waitlist on August 1
- TWOPAGES Partners with Brexton Cole Interiors to Launch "The Wildwood Loom"
- Be Strong Announces New Leadership and the Next Chapter of Its Legacy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share